Login to Your Account



NewCo News: Mission Raises $9.8M for New Area of Enzymology

By Nuala Moran


Thursday, August 25, 2011
LONDON – The scientists behind KuDOS Pharmaceuticals Ltd., which was sold to London-based AstraZeneca plc in December 2005 for £121.5 million (then US$210 million), have left the company to form another start-up, Mission Therapeutics Ltd.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription